Pathological complete remission of relapsed tumor by photo‐activating antibody–mimetic drug conjugate treatment

Author:

Kaneko Yudai12ORCID,Yamatsugu Kenzo3,Yamashita Takefumi1,Takahashi Kazuki3,Tanaka Toshiya1,Aki Sho1,Tatsumi Toshifumi3,Kawamura Takeshi14,Miura Mai1,Ishii Masazumi1,Ohkubo Kei56,Osawa Tsuyoshi1,Kodama Tatsuhiko1,Ishikawa Shumpei7,Tsukagoshi Masanobu8,Chansler Michael8,Sugiyama Akira14ORCID,Kanai Motomu3,Katoh Hiroto7ORCID

Affiliation:

1. Research Center for Advanced Science and Technology The University of Tokyo Tokyo Japan

2. Medical & Biological Laboratories Co., Ltd Tokyo Japan

3. Graduate School of Pharmaceutical Sciences The University of Tokyo Tokyo Japan

4. Isotope Science Center The University of Tokyo Tokyo Japan

5. Institute for Open and Transdisciplinary Research Initiatives Osaka University Osaka Japan

6. Institute for Advanced Co‐Creation Studies, Osaka University Osaka Japan

7. Department of Preventive Medicine, Graduate School of Medicine The University of Tokyo Tokyo Japan

8. Savid Therapeutics Inc. Tokyo Japan

Funder

Japan Society for the Promotion of Science

Kowa Life Science Foundation

Takeda Science Foundation

Japan Agency for Medical Research and Development

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3